Gluconeogenesis is the metabolic pathway that builds new glucose from non-sugar starting materials, primarily in the liver, and it is what keeps your blood sugar from crashing every time you go more than a few hours without eating. The pathway shares most of its steps with glycolysis running in reverse but has to work around three energetically irreversible reactions by using a different set of enzymes. What makes gluconeogenesis genuinely interesting, beyond textbook biochemistry, is how deeply it connects to everyday physiology: fasting, exercise, diabetes treatment, protein-rich diets, circadian rhythms, and even the evolutionary history of life on Earth.
What Feeds Into the Pathway
Your body can manufacture glucose from several raw materials. The main ones are lactate, certain amino acids (especially alanine and glutamine), and glycerol released from the breakdown of stored fat. Each enters the pathway at a slightly different point, but they all converge on the same central route that ends with free glucose being released into the bloodstream.
Lactate is probably the single most important substrate in everyday life. Muscles produce it during intense activity, and it travels through the blood to the liver, where it gets converted back into glucose and sent right back out for the muscles to use again. This recycling loop, known as the Cori cycle, is a cornerstone of how your body manages energy during exercise. Research in mice has shown that enhancing this cycle in the liver, specifically by boosting the conversion of lactate into glucose, can significantly lower dangerous blood lactate levels during exertion.
Amino acids, particularly alanine, are the next major contributor. During prolonged fasting or starvation, amino acids from muscle protein become the dominant raw material for making glucose, with the kidneys also getting involved by processing glutamine and recovering its carbon skeleton as glucose.1Encyclopedia of Life Sciences. Starvation: Metabolic Changes This is why extended calorie restriction leads to muscle loss: your body is literally dismantling protein to keep blood sugar stable.
Glycerol, freed when stored fat is broken down, also feeds into the pathway. Interestingly, in human studies, infusing extra alanine or glycerol into fasted volunteers did not simply ramp up total glucose output. Instead, glycerol appeared to competitively squeeze out amino acid-based glucose production, suggesting the pathway has built-in limits rather than scaling up indefinitely when more raw material arrives.2PubMed. The relationship between gluconeogenic substrate supply and glucose production in humans The body does not just pour in more ingredients and expect proportionally more glucose. It tightly manages which substrates get priority.
The Three Bypass Reactions
Glycolysis, the pathway that breaks glucose down for energy, has three steps that release so much energy they are effectively one-way streets. Gluconeogenesis cannot simply reverse those steps, so it uses different enzymes to get around them. These three bypass reactions are what make gluconeogenesis its own distinct pathway rather than glycolysis played in reverse.
The first bypass converts pyruvate to phosphoenolpyruvate (PEP), and it actually takes two enzymes working in sequence. Pyruvate carboxylase, inside the mitochondria, first converts pyruvate to oxaloacetate. Then PEP carboxykinase (PEPCK) converts oxaloacetate to PEP. What is striking about PEPCK is that its relationship to glucose output is not straightforward. In mice engineered to have only about a tenth of the normal amount of PEPCK protein in their livers, glucose production dropped by roughly 40%, not the 90% you might expect. This suggests that PEPCK does not act as a simple throttle on the pathway; its activity is intertwined with the broader energy metabolism of the cell, particularly the activity of the TCA cycle.3PubMed Central. Fructose 1,6-bisphosphatase: getting the message across
The second bypass involves fructose-1,6-bisphosphatase (FBPase), which strips a phosphate group from fructose-1,6-bisphosphate. This enzyme sits at a critical regulatory crossroads. It is inhibited by a signaling molecule called fructose-2,6-bisphosphate, which acts as a metabolic switch: when levels of that signaling molecule are high, the cell favors burning glucose for energy, and gluconeogenesis is suppressed.4PubMed. Roles for fructose-2,6-bisphosphate in the control of fuel metabolism: beyond its allosteric effects on glycolytic and gluconeogenic enzymes FBPase is also inhibited by AMP, a molecule that accumulates when the cell is low on energy. This dual sensitivity makes FBPase a gatekeeper that only lets gluconeogenesis proceed when conditions are right.
The third bypass is the final step of the whole pathway. Glucose-6-phosphatase (G6Pase) removes the last phosphate group from glucose-6-phosphate to produce free glucose that can leave the cell and enter the bloodstream. This enzyme is embedded in the membrane of the endoplasmic reticulum, with its active site facing inward. Glucose-6-phosphate has to be transported into the ER lumen, the phosphate gets clipped off inside, and then both glucose and the freed phosphate have to be shuttled back out.5PubMed Central. Structural insights into glucose-6-phosphate recognition and hydrolysis by human G6PC1 This unusual arrangement means G6Pase relies on a set of transporter proteins just to do its job. Only tissues that express the full G6Pase system, mainly the liver and to some extent the kidneys and intestines, can actually release free glucose into the blood.
Getting Intermediates Out of the Mitochondria
One underappreciated aspect of gluconeogenesis is that part of it happens inside the mitochondria and part happens in the cell’s main compartment, the cytosol. The intermediate oxaloacetate, produced inside the mitochondria, cannot easily cross the mitochondrial membrane on its own. The traditional explanation is that it gets converted to malate, which can cross the membrane, and is then converted back to oxaloacetate on the other side.
But recent work has added nuance to this picture. It turns out that malate is the preferred shuttle mainly when fatty acid oxidation is running high, as it does during fasting or uncontrolled diabetes. Under other conditions, the cell uses a different route: oxaloacetate is converted to aspartate inside the mitochondria, and aspartate is then transported out to the cytosol via a dedicated carrier protein (AGC2), swapping places with glutamate coming in the opposite direction.6PubMed. Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states This means the cell has at least two ways to move gluconeogenic carbon out of the mitochondria, and which one dominates depends on what else is going on metabolically. The aspartate route has been largely overlooked in standard descriptions of the pathway.
How Hormones Keep the Pathway in Check
Gluconeogenesis is under tight hormonal control, and the two heavyweights are insulin and glucagon. Glucagon, released when blood sugar drops, turns the pathway on. Insulin, released after a meal when blood sugar rises, shuts it down. Insulin works in part by suppressing the genes that encode PEPCK and G6Pase, the key bypass enzymes. When insulin signaling is impaired, as in type 2 diabetes, the liver keeps churning out glucose even after a meal, when it should be stopping. This failure to suppress gluconeogenesis in the fed state is a major driver of the chronically elevated blood sugar seen in diabetes.7PubMed Central. Insulin regulation of gluconeogenesis
Cortisol, the stress hormone, also ramps up gluconeogenesis by promoting muscle protein breakdown (providing amino acid substrates) and by boosting the expression of gluconeogenic enzymes. This is why chronic stress or long-term corticosteroid use can push blood sugar upward, even in people who are not diabetic.
Metformin and the Pathway
Metformin, the most widely prescribed drug for type 2 diabetes, owes a significant part of its blood-sugar-lowering effect to suppressing hepatic gluconeogenesis. For years, the dominant explanation was that metformin works by inhibiting mitochondrial complex I, which raises AMP levels and activates an energy-sensing enzyme called AMPK. But research has complicated that story. Studies in mice that lack AMPK in the liver showed that metformin still lowered blood sugar, casting doubt on AMPK as the sole explanation.
A study published in Nature Medicine identified a more direct mechanism: metformin inhibits fructose-1,6-bisphosphatase, the second bypass enzyme described above, by increasing the concentration of AMP that binds to and suppresses FBPase. This makes FBPase a major contributor to metformin’s therapeutic action, alongside whatever mitochondrial effects the drug has.8PubMed Central. Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase For patients, the practical takeaway is that metformin is not just vaguely “helping insulin work better.” It is physically blocking one of the key enzymes that makes new glucose.
When the Pathway Breaks Down
Genetic defects in gluconeogenic enzymes are rare but can be severe, especially in young children. FBPase deficiency is perhaps the best-characterized example. Children with this condition cannot complete one of the three bypass reactions, and they are vulnerable to episodes of dangerously low blood sugar, lactic acid buildup, and metabolic acidosis, typically triggered by fasting or illness. A case report of a pediatric patient with compound mutations in the FBP1 gene described exactly this pattern: hypoglycemia, elevated blood lactate, acidosis, and high uric acid levels.9PubMed Central. Novel compound heterozygous mutations of the FBP1 gene in a patient with hypoglycemia and lactic acidosis: A case report These children can live normal lives with careful dietary management, particularly by avoiding long fasts and keeping fructose and sorbitol intake low, but diagnosis is often delayed because the episodes can look like other childhood illnesses.
Glycogen storage disease type I, caused by deficiency of glucose-6-phosphatase, is another well-known example. Without that final enzyme, the liver can make glucose-6-phosphate but cannot release free glucose. The result is severe fasting hypoglycemia, a massively enlarged liver packed with glycogen it cannot properly mobilize, and elevated lactate and lipids. These genetic conditions underscore how essential each bypass reaction is for survival.
Not Just a Liver Story
While the liver handles the bulk of gluconeogenesis, it is not the only organ that can make new glucose. The kidneys contribute meaningfully, especially during prolonged fasting and in conditions like metabolic acidosis. In acidotic conditions, kidney cortex tissue ramps up its use of glutamine as a gluconeogenic substrate, producing glucose and releasing ammonium in a process that simultaneously helps correct the acid-base imbalance.10JCI Insight. Pathways of glutamine and organic acid metabolism in renal cortex in chronic metabolic acidosis Some estimates suggest the kidneys can account for up to a quarter of total glucose production during extended fasts.
More surprising is the role of the small intestine. Intestinal gluconeogenesis was long considered negligible, but research over the past two decades has revealed it plays a role in appetite regulation and whole-body glucose control. Glucose produced by the intestine is sensed by nerves in the portal vein, the blood vessel that drains the gut into the liver. This portal glucose signal travels to the brain and reduces hunger.11PubMed. Intestinal glucose metabolism revisited This mechanism helps explain why high-protein diets tend to be more satiating: peptides from protein digestion trigger intestinal gluconeogenesis, and the resulting portal glucose signal suppresses appetite.12PubMed. Satiety and the role of μ-opioid receptors in the portal vein The gut is not just absorbing nutrients passively; it is actively manufacturing glucose as part of a signaling system.
Gluconeogenesis on a Clock
Your liver does not produce glucose at a constant rate throughout the day. Gluconeogenesis follows a circadian rhythm, ramping up and down on a roughly 24-hour cycle that is coordinated with feeding patterns and the body’s internal clock. Research in mice has shown that a protein-degradation system in the liver, involving the E3 ubiquitin ligase HRD1, exhibits circadian rhythmicity and controls the abundance of transcriptional activators that drive gluconeogenic gene expression. When HRD1 was knocked out in mouse livers, the normal circadian profiles of blood glucose, triglycerides, and fatty acids were disrupted, with gluconeogenic gene expression elevated beyond its usual rhythmic pattern.13PubMed Central. Insulin regulation of gluconeogenesis
This circadian regulation has practical implications. It is part of the reason blood sugar tends to rise in the early morning hours, a phenomenon sometimes called the “dawn phenomenon” in people with diabetes. The liver’s gluconeogenic output naturally increases overnight, timed to prepare the body for waking and activity. In healthy individuals, a corresponding rise in insulin keeps things in check. In diabetes, where insulin signaling is impaired, the overnight surge in liver glucose production goes unchecked, and fasting morning blood sugar readings are disproportionately high.
How Ruminants Depend on the Pathway
In human metabolism, gluconeogenesis is important but supplementary; you also absorb glucose directly from dietary carbohydrates. In ruminant animals like cattle, the situation is radically different. Because bacteria in the rumen ferment nearly all dietary carbohydrates into volatile fatty acids before they can be absorbed as glucose, ruminants depend on gluconeogenesis almost entirely for their glucose supply. The main gluconeogenic substrate in cattle is propionate, one of the volatile fatty acids produced by rumen fermentation.14PubMed. Gluconeogenesis in cattle: significance and methodology A dairy cow producing large volumes of milk, which requires substantial glucose for lactose synthesis, has an enormous gluconeogenic demand. This makes the pathway not just a metabolic backup system in ruminants but the primary route for glucose provision, a fundamentally different metabolic architecture from what we see in humans.
An Ancient Pathway That Came First
There is a fascinating evolutionary wrinkle to gluconeogenesis. Most people, if they think about it at all, assume that glycolysis (breaking down glucose) is the “original” pathway and gluconeogenesis (building glucose up) is the derived version. The evolutionary evidence suggests the opposite. Glycogen synthesis and gluconeogenesis are universal among prokaryotes, but glycolysis is not, meaning the glucose-building direction appears to be older.15PubMed Central. The early evolution of the glycolytic pathway from autotrophic origins to glycogen and back In this view, the earliest organisms were autotrophs that built sugar molecules from simple carbon compounds like CO₂, and the enzymes we now think of as “glycolytic” originally ran in the gluconeogenic direction. Only later, once sugar reserves like glycogen existed and organisms evolved the ability to feed on organic material, did glycolysis as a catabolic (breakdown) pathway emerge.
Supporting evidence comes from archaea, an ancient domain of life distinct from bacteria. Some archaea perform gluconeogenesis using a reversed version of what later became a standard glycolytic route, and they appear to have done so before the key regulatory enzymes that make glycolysis a dedicated breakdown pathway had evolved.16Research in Microbiology. Evolution of carbohydrate metabolic pathways The pathway you activate every morning before breakfast, in other words, is one of the most ancient metabolic processes on the planet, predating the ability to eat sugar rather than build it.
The Lactate Recycling Connection
The Cori cycle, mentioned earlier as the recycling of lactate between muscles and liver, deserves a closer look because of its medical significance. In critical illness, when tissue oxygen delivery is compromised, lactate levels in the blood rise sharply. Lactic acidosis is a dangerous condition associated with sepsis, liver failure, and other emergencies. The liver’s capacity for gluconeogenesis from lactate is the body’s primary defense against lactate buildup.
Mouse studies have shown that enhancing this capacity, by genetically activating the hypoxic response specifically in the liver, significantly increased the conversion of labeled lactate into glucose and lowered blood lactate levels during both exercise and direct lactate challenge.17PubMed Central. Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle While this research is preclinical, it illustrates the principle that gluconeogenesis is not merely about supplying glucose. It also serves as a disposal system for metabolic waste products, clearing lactate by pulling it back into a useful form. When liver function declines, whether from disease, surgery, or drug toxicity, one of the early consequences is impaired lactate clearance, precisely because the gluconeogenic machinery is faltering.